These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12962042)

  • 1. [Design of the novel dipeptide neuropsychotropic drug preparations].
    Gudasheva TA; Skoldinov AP
    Eksp Klin Farmakol; 2003; 66(2):15-9. PubMed ID: 12962042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Technologies for Dipeptide Drugs Design and their Implantation.
    Gudasheva TA; Ostrovskaya RU; Seredenin SB
    Curr Pharm Des; 2018; 24(26):3020-3027. PubMed ID: 30295186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The original novel nootropic and neuroprotective agent noopept].
    Ostrovskaia RU; Gudasheva TA; Voronina TA; Seredenin SB
    Eksp Klin Farmakol; 2002; 65(5):66-72. PubMed ID: 12596521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
    Ostrovskaya RU; Gruden MA; Bobkova NA; Sewell RD; Gudasheva TA; Samokhin AN; Seredinin SB; Noppe W; Sherstnev VV; Morozova-Roche LA
    J Psychopharmacol; 2007 Aug; 21(6):611-9. PubMed ID: 17092975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurotensine dipeptide analog dilept decreases the deficiency of prestimulus startle reflex inhibition: a prognostic sign of antipsychotic activity].
    Ostrovskaia RU; Krupina NA; Gudasheva TA; Voronina TA; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(5):3-7. PubMed ID: 19928566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Strategy for the development of dipeptide drugs].
    Gudasheva TA
    Vestn Ross Akad Med Nauk; 2011; (7):8-16. PubMed ID: 21899085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the novel dipeptide nootropic agent noopept and its metabolite cyclo-L-prolylglycine on the transcallosal evoked potential in the rat brain].
    Molodavkin GM; Borlikova GG; Voronina TA; Gudasheva TA; Ostrovskaia RU; Tushmalova NA; Seredenin SB
    Eksp Klin Farmakol; 2002; 65(2):3-5. PubMed ID: 12109288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel endogenous dipeptide cycloprolyl-glycine is similar to pyracetam in selectivity of their mnemotropic effect].
    Gudasheva TA; Ostrovskaia RU; Trofimov SS; Voronina TA; Skoldinov AP; Seredenin SB
    Biull Eksp Biol Med; 1999 Oct; 128(10):411-3. PubMed ID: 10599497
    [No Abstract]   [Full Text] [Related]  

  • 9. [The comparative characteristics of the effect of piracetam peptide analogs on the recovery of conditioned reflex activity in animals following damage to the frontal cortex and the electrophysiological characteristics of the brain integrative activity].
    Romanova GA; Gudasheva TA; Dobrynin VP; Ostrovskaia RU
    Eksp Klin Farmakol; 1992; 55(5):6-8. PubMed ID: 1305458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites].
    Boĭko SS; Zherdev VP; Dvorianinov AA; Gudasheva TA; Ostrovskaia RU; Voronina TA; Rozantsev GG; Seredenin SB
    Eksp Klin Farmakol; 1997; 60(2):53-5. PubMed ID: 9206571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early postnatal effects of noopept and piracetam on declarative and procedural memory of adult male and female rats.
    Trofimov SS; Voronina TA; Guzevatykh LS
    Bull Exp Biol Med; 2005 Jun; 139(6):683-7. PubMed ID: 16224581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration.
    Ostrovskaya RU; Mirsoev TK; Romanova GA; Gudasheva TA; Kravchenko EV; Trofimov CC; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2001 Oct; 132(4):959-62. PubMed ID: 11782792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
    Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
    ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine.
    Gudasheva TA; Boyko SS; Ostrovskaya RU; Voronina TA; Akparov VK; Trofimov SS; Rozantsev GG; Skoldinov AP; Zherdev VP; Seredenin SB
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):245-52. PubMed ID: 9358206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs.
    Scapecchi S; Martelli C; Ghelardini C; Guandalini L; Martini E; Gualtieri F
    Farmaco; 2003 Sep; 58(9):715-22. PubMed ID: 13679165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dipeptide nootropic agent GVS-111 prevents accumulation of the lipid peroxidation products during immobilization].
    Lysenko AV; Uskova NI; Ostrovskaia RU; Gudasheva TA; Voronina TA
    Eksp Klin Farmakol; 1997; 60(5):15-8. PubMed ID: 9483398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavioral and electrophysiologic characteristics of a peptide analog of piracetam--L-pyroglutamyl-D-alanine amide].
    Ostrovskaia RU; Gudasheva TA; Trofimov SS; Romanova GA; Dobrynin VP
    Biull Eksp Biol Med; 1987 Nov; 104(11):576-9. PubMed ID: 3676493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of noopept and its active metabolite cycloprolyl glycine in rats].
    Boyko SS; Zherdev VP; Shevchenko RV
    Biomed Khim; 2018 Sep; 64(5):455-458. PubMed ID: 30378564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptide Piracetam Analogue Noopept Improves Viability of Hippocampal HT-22 Neurons in the Glutamate Toxicity Model.
    Antipova TA; Nikolaev SV; Ostrovskaya PU; Gudasheva TA; Seredenin SB
    Bull Exp Biol Med; 2016 May; 161(1):58-60. PubMed ID: 27265136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interstrain differences in the content of excitatory and inhibitory amino acids in the brain of DBA/2J, Balb/c and C57BL/6 mice: characteristics of the effect of a dipeptide antipsychotic drug dilept].
    Shubenina EB; Kudrin VS; Klodt PM; Pokrovskiĭ AA; Gudasheva TA; Voronina TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2008; 71(4):7-10. PubMed ID: 18819433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.